肿瘤浸润T细胞受体β库与局部晚期鼻咽癌放化疗后晚期颞叶坏死风险相关
本研究在连续收治的T3-4N0-3M0鼻咽癌患者中评估同步放化疗后颞叶坏死(TLN)发生率,采用剂量体积直方图、中性粒细胞与淋巴细胞比值(NLR)及肿瘤浸润淋巴细胞TCRβ高通量测序分析风险因素。T4患者TLN发生率30.14%高于T3患者的2.78%(P < .0001);T4患者中放疗剂量体积效应并非绝对独立因素,而NLR升高及TCRβ库亚型与TLN风险相关,两者联合可更好预测TLN风险。
要点
- T4期鼻咽癌患者同步放化疗后TLN发生率为30.14%,显著高于T3期的2.78%(P < .0001)。
- T4患者中放疗剂量体积效应并非TLN发生的绝对独立因素。
- 放化疗前基线及放化疗后NLR升高与TLN风险增加相关。
核心结论
- T4期鼻咽癌患者中肿瘤浸润淋巴细胞库和血循环NLR与TLN发生相关,提示免疫和炎症微环境在放化疗所致晚期脑损伤中起作用。
- 局部和全身放化疗调控或激发的中性粒细胞与淋巴细胞在颅内鼻咽癌相关免疫微环境中的相互作用可能是慢性TLN发病的关键驱动因素。
研究设计与样本
- 连续纳入初诊T3-4N0-3M0鼻咽癌患者,接受根治性调强放疗(IMRT)联合顺铂为基础的化疗并长期随访,评估同步放化疗诱导的TLN发生率。
- 采用线性及逻辑回归模型,结合放疗剂量体积直方图(器官损伤的剂量学风险指标)和血循环NLR动态(全身炎症的临床指标)评估TLN风险。
- 对鼻咽癌浸润淋巴细胞进行高通量无偏TCRβ测序,分析不同TCRβ库与TLN发生率的相关性。
主要发现
- 现代IMRT同步放化疗时代,放疗剂量高达74 Gy时T3和T4期病变局部控制率均超过90%,但T4患者TLN发生率30.14%显著高于T3患者的2.78%(P < .0001)。
- T4期鼻咽癌患者中,单因素和多因素分析显示放疗耐受剂量体积效应并非影响TLN发生的绝对独立因素。
- T4期患者中,放化疗前基线及放化疗后NLR升高与TLN风险增加相关。
- 肿瘤内TCRβ库亚型与TLN发生率存在关联。
- 将TCRβ基因组易感性与临床变量NLR联合,能更好预测T4期鼻咽癌患者同步放化疗后TLN风险。
关键数值与推荐
- T4期患者TLN发生率为30.14%,T3期患者为2.78%,组间比较P < .0001。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Temporal lobe necrosis (TLN), a late complication of nasopharyngeal carcinoma (NPC) after concurrent chemoradiotherapy (CCRT), causes permanent neurologic deficits. We aimed to investigate the risk factors for the development of CCRT-induced TLN in locally advanced NPC patients. METHODS AND MATERIALS: The incidence of CCRT-induced TLN was assessed in consecutive patients with NPC initially staged with T3-4N0-3M0 receiving curative intensity modulated radiation therapy (IMRT) and cisplatin-based chemotherapy with long-term follow-up. The TLN risk was evaluated with radiation dose-volume histograms (a dosimetric risk indicator of organ injury) and the dynamics of blood circulating neutrophil-to-lymphocyte ratios (a clinical indicator of systemic inflammation) by linear and logistic regression models. High-throughput unbiased T cell receptor-beta (TCRbeta) sequencing was performed to correlate the different TCRbeta repertoires of NPC-infiltrating lymphocytes (a biological factor of the immune microenvironment) with TLN incidence. RESULTS: In the era of modern IMRT-based CCRT, radiation doses of up to 74 Gy achieved local control rates of more than 90% in both T3 and T4 diseases but still induced a remarkably higher incidence of TLN in the T4 patients (30.14%) compared with the rare incidence of TLN observed in the T3 patients (2.78%) (P < .0001). We found that in the T4 NPC patients, univariate and multivariate analyses showed the radiation tolerance dose-volume effect was not an absolutely independent factor influencing TLN occurrence. However, increased TLN risk was observed in association with higher pre-CCRT baseline and post-CCRT neutrophil-to-lymphocyte ratios. There was also a link between intratumoral TCRbeta repertoire subtypes and TLN incidence. Combining the inherent TCRbeta genomic susceptibility with the clinical variable neutrophil-to-lymphocyte ratio better predicted the risk of TLN for T4 NPC patients after CCRT. CONCLUSIONS: The associations of tumor-infiltrating lymphocyte repertoires and blood circulating neutrophil-to-lymphocyte ratios with TLN occurrence in T4 NPC patients suggest that the immune and inflammatory milieus play roles in the late brain damage caused by CCRT. Modulated or provoked by CCRT locally and systemically, the reciprocal interactions of neutrophils and lymphocytes in the intracranial NPC-associated immune microenvironment could be a key driver of chronic TLN pathogenesis.
引用
- Wu L, Chung YL. Tumor-Infiltrating T Cell Receptor-Beta Repertoires are Linked to the Risk of Late Chemoradiation-Induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2019. PMID: 30654091. doi:10.1016/j.ijrobp.2019.01.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。